Citations for
1EIF5A, LHCGR, MVK
LHCGR Expression During FSH-Induced Follicle Growth is Negatively Regulated by Eukaryotic Initiation Factor 5A.
Gulappa T, Menon B, Menon KMJ.
Endocrinology ndocrinology. 2017 Jun 9. doi: 10.1210/en.2017-00113. [Epub ahead of print] 2017
2MVK, POROK3
Identification of three mutations in the MVK gene in six patients associated with disseminated superficial actinic porokeratosis.
Liu Y, Wang J, Qin Y, Huang C, Archacki S, Ma J, Li D, Liu M.
Clin Chim Acta 454:124-9. doi: 10.1016/j.cca.2016.01.009. Epub 2016 Jan 12. 2016
3MVK
Quantification of mevalonate-5-phosphate using UPLC-MS/MS for determination of mevalonate kinase activity.
Reitzle L, Maier B, Stojanov S, Teupser D, Muntau AC, Vogeser M, Gersting SW.
Clin Biochem 48(12):781-7. doi: 10.1016/j.clinbiochem.2015.05.007. Epub 2015 May 13. 2015
4MVK, POROK3
A novel MVK missense mutation in one Chinese family with disseminated superficial actinic porokeratosis.
Lu WS, Zheng XD, Yao XH, Zhang LF, Wang MQ, Jiang FX, Zhang SP, Hu B.
Mol Biol Rep 41(11):7229-33. doi: 10.1007/s11033-014-3609-4. Epub 2014 Jul 25. 2014
5MVK, POROK3
Identification of three novel frameshift mutations of the MVK gene in four Chinese families with disseminated superficial actinic porokeratosis.
Zhou Y, Liu J, Fu X, Yu Y, Shi B, Yu G, Shi Z, Wu W, Pan F, Tian H, Liu H, Zhang F.
Br J Dermatol 169(1):193-5. doi: 10.1111/bjd.12224. No abstract available. 2013
6MVK, POROK3
Exome sequencing identifies MVK mutations in disseminated superficial actinic porokeratosis.
Zhang SQ, Jiang T, Li M, Zhang X, Ren YQ, Wei SC, Sun LD, Cheng H, Li Y, Yin XY, Hu ZM, Wang ZY, Liu Y, Guo BR, Tang HY, Tang XF, Ding YT, Wang JB, Li P, Wu BY, Wang W, Yuan XF, Hou JS, Ha WW, Wang WJ, Zhai YJ, Wang J, Qian FF, Zhou FS, Chen G, Zuo XB, Zheng XD, Sheng YJ, Gao JP, Liang B, Li P, Zhu J, Xiao FL, Wang PG, Cui Y, Li H, Liu SX, Gao M, Fan X, Shen SK, Zeng M, Sun GQ, Xu Y, Hu JC, He TT, Li YR, Yang HM, Wang J, Yu ZY, Zhang HF, Hu X, Yang K, Wang J, Zhao SX, Zhou YW, Liu JJ, Du WD, Zhang L, Xia K, Yang S, Wang J, Zhang XJ.
Nat Genet 44(10):1156-60. doi: 10.1038/ng.2409. Epub 2012 Sep 16. 2012
7HIDS, MVK
Hyper-IgD syndrome with novel mutation in a Japanese girl.
Naruto T, Nakagishi Y, Mori M, Miyamae T, Imagawa T, Yokota S.
Mod Rheumatol 19(1):96-9. doi: 10.1007/s10165-008-0130-4. Epub 2008 Oct 22. 2009
8LHCGR, MVK
Regulation of luteinizing hormone receptor mRNA expression by mevalonate kinase--role of the catalytic center in mRNA recognition.
Nair AK, Young MA, Menon KM.
FEBS J 275(13):3397-407. doi: 10.1111/j.1742-4658.2008.06490.x. Epub 2008 May 20. 2008
9HIDS, MVK, MVKD
MVK mutations and associated clinical features in Italian patients affected with autoinflammatory disorders and recurrent fever.
D'Osualdo A, Picco P, Caroli F, Gattorno M, Giacchino R, Fortini P, Corona F, Tommasini A, Salvi G, Specchia F, Obici L, Meini A, Ricci A, Seri M, Ravazzolo R, Martini A, Ceccherini I.
Eur J Hum Genet 13(3):314-20. 2005
10HIDS, MVK, MVKD, TNFRSF1A, TRAPS
Molecular analysis of the MVK and TNFRSF1A genes in patients with a clinical presentation typical of the hyperimmunoglobulinemia D with periodic fever syndrome: a low-penetrance TNFRSF1A variant in a heterozygous MVK carrier possibly influences the phenotype of hyperimmunoglobulinemia D with periodic fever syndrome or vice versa.
Stojanov S, Lohse P, Lohse P, Hoffmann F, Renner ED, Zellerer S, Kery A, Shin YS, Haas D, Hoffmann GF, Belohradsky BH.
Arthritis Rheum 50(6):1951-8. 2004
11MVK
Isolation and characterization of a novel trans-factor for luteinizing hormone receptor mRNA from ovary.
Nair AK, Menon KM.
J Biol Chem 279(15):14937-44. Epub 2004 Jan 28. 2004
12HIDS, MVK, MVKD
Molecular analysis of MVK mutations and enzymatic activity in hyper-IgD and periodic fever syndrome.
Cuisset L, Drenth JP, Simon A, Vincent MF, van Der Velde Visser S, van Der Meer JW, Grateau G, Delpech M.
Eur J Hum Genet 9(4):260-6. 2001
13HIDS, MVK, MVKD
Organization of the mevalonate kinase (MVK) gene and identification of novel mutations causing mevalonic aciduria and hyperimmunoglobulinaemia D and periodic fever syndrome.
Houten SM, Koster J, Romeijn GJ, Frenkel J, Di Rocco M, Caruso U, Landrieu P, Kelley RI, Kuis W, Poll-The BT, Gibson KM, Wanders RJ, Waterham HR.
Eur J Hum Genet 9(4):253-9. 2001
14HIDS, MVK, MVKD
Mutations in MVK, encoding mevalonate kinase, cause hyperimmunoglobulinaemia D and periodic fever syndrome.
Houten SM, et al.
Nat Genet 22(2):175-7. 1999
15HIDS, MVK, MVKD
Mutations in the gene encoding mevalonate kinase cause hyper-IgD and periodic fever syndrome. International Hyper-IgD Study Group.
Drenth JP, et al.
Nat Genet 22(2):178-81. 1999
16MVK, MVKD
Identification and characterization of three novel missense mutations in mevalonate kinase cDNA causing mevalonic aciduria, a disorder of isoprene biosynthesis.
Houten SM, et al.
Hum Mol Genet 8(8):1523-8. 1999
17MVK, MVKD
Identification of a mutation cluster in mevalonate kinase deficiency, including a new mutation in a patient of Mennonite ancestry.
Hinson DD, et al.
Am J Hum Genet 65(2):327-35 1999
18MVK
Mevalonate kinase map position 12q24.
Gibson KM, et al.
Chromosome Res 5 : 150. 1997
19MVK, MVKD
Clinical and biochemical phenotype in 11 patients with mevalonic aciduria.
Hoffmann GF, et al.
Pediatrics 91 : 915-921. 1993
20MVK
Molecular cloning of human mevalonate kinase and identification of a missense mutation in the genetic disease mevalonic aciduria.
Schafer BL, et al.
J Biol Chem 267 : 13229-13238. 1992